| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |